Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaowei Qiu

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Oncotarget|May 28, 2015
A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cellsJing Yu, Shaowei Qiu, Qiufu Ge, et al.
Human Gene Therapy|October 20, 2023
Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T CellsLeling Xie, Runxia Gu, Xue Yang, et al.
Leukemia Research|April 8, 2014
N-Cadherin and Tie2 positive CD34⁺CD38⁻CD123⁺ leukemic stem cell populations can develop acute myeloid leukemia more effectively in NOD/SCID miceShaowei Qiu, Yujiao Jia, Haiyan Xing, et al.
Molecular Oncology|June 26, 2024
Slow-replicating leukemia cells represent a leukemia stem cell population with high cell-surface CD74 expressionHuan Li, Zhijie Cao, Yiming Liu, et al.
Cytotherapy|July 30, 2023
2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathwayJunli Mou, Leling Xie, Yingxi Xu, et al.
Oncology Letters|September 21, 2017
Regulation of HtrA2 on WT1 gene expression under imatinib stimulation and its effects on the cell biology of K562 cellsLixia Zhang, Yan Li, Xiaoyan Li, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 15, 2024
A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cellsZhifeng Yan, Runxia Gu, Haotian Ma, et al.
Cancer Gene Therapy|August 7, 2023
A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effectsZhe Wang, Ting Liu, Wenbing Liu, et al.
Molecular Oncology|July 7, 2025
The critical role of DNA damage-inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiationYishuang Li, Zhijie Cao, Haiyan Xing, et al.
Haematologica|April 16, 2026
Durable deep molecular response via CD19 chimeric antigen receptor T-cell therapy combined with a third-generation tyrosine kinase inhibitor in acute leukemia of ambiguous lineage with the Philadelphia chromosome: a potential strategy for transplant-ineligible patientsAo Zhang, Benfa Gong, Yuntao Liu, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Oncotarget|May 28, 2015
A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cellsJing Yu, Shaowei Qiu, Qiufu Ge, et al.
Human Gene Therapy|October 20, 2023
Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T CellsLeling Xie, Runxia Gu, Xue Yang, et al.
Leukemia Research|April 8, 2014
N-Cadherin and Tie2 positive CD34⁺CD38⁻CD123⁺ leukemic stem cell populations can develop acute myeloid leukemia more effectively in NOD/SCID miceShaowei Qiu, Yujiao Jia, Haiyan Xing, et al.
Molecular Oncology|June 26, 2024
Slow-replicating leukemia cells represent a leukemia stem cell population with high cell-surface CD74 expressionHuan Li, Zhijie Cao, Yiming Liu, et al.
Cytotherapy|July 30, 2023
2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathwayJunli Mou, Leling Xie, Yingxi Xu, et al.
Oncology Letters|September 21, 2017
Regulation of HtrA2 on WT1 gene expression under imatinib stimulation and its effects on the cell biology of K562 cellsLixia Zhang, Yan Li, Xiaoyan Li, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 15, 2024
A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cellsZhifeng Yan, Runxia Gu, Haotian Ma, et al.
Cancer Gene Therapy|August 7, 2023
A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effectsZhe Wang, Ting Liu, Wenbing Liu, et al.
Molecular Oncology|July 7, 2025
The critical role of DNA damage-inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiationYishuang Li, Zhijie Cao, Haiyan Xing, et al.
Haematologica|April 16, 2026
Durable deep molecular response via CD19 chimeric antigen receptor T-cell therapy combined with a third-generation tyrosine kinase inhibitor in acute leukemia of ambiguous lineage with the Philadelphia chromosome: a potential strategy for transplant-ineligible patientsAo Zhang, Benfa Gong, Yuntao Liu, et al.
Pageof 7